Alpaca

Alpaca is a biotechnology company specializing in the discovery and development of nanobodies, which are small, single-domain antibody fragments derived from camelids. The company utilizes a proprietary high-throughput platform that integrates synthetic biology and computational tools to identify high-affinity binders for challenging therapeutic targets. Alpaca's mission is to expand the reach of biologics by creating stable, modular, and highly specific molecules capable of penetrating tissues and binding to cryptic epitopes that traditional antibodies cannot access. The platform is designed to accelerate the development of novel therapies for oncology, immunology, and infectious diseases.